health
Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today begins trading as a constituent of the Swiss Market Index (SMI), Switzerland's leading blue chip equity benchmark comprising 20 of the country's largest and most liquid listed companies. Less than three years after its IPO on the SIX Swiss Exchange in March 2024, Galderma has established itself as one of Switzerland's leading listed companies. Its inclusion in the SMI reflects the company's
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories

Overprescribing can take a toll on older peoples’ health and independence - here’s what can be done
The Conversation

Only 2pc can spot signs of common heart risk
New England Times
Victoria’s Dedicated Health Workforce Deliver Record Care
The National Tribune
New Program to Fast-Track Provincial Clinical Trials
Mirage News

Oral HRT link with blood clots
Pharmacy Daily